文献速递前列腺癌膀胱癌与上尿路尿路上皮癌

前列腺癌放疗诱发出血性膀胱炎的发病率与疾病负担

Incidence and Morbidity of Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer.
PubMed 文献 · Urology · 2019-06-12

该回顾性研究分析了2000年1月至2015年9月两家底特律医学中心709例接受放疗的前列腺癌患者,出血性膀胱炎发病率为11.1%,外照射与调强放疗间无显著差异(P=0.18),中位发病时间79.1个月,患者需多次住院、输血和手术,并发症包括尿路感染、急性肾损伤、尿脓毒症甚至死亡。

要点

  • 前列腺癌放疗后出血性膀胱炎发病率为11.1%,外照射与调强放疗无显著差异(P=0.18)。
  • 出血性膀胱炎平均于放疗后79.1个月发生,平均住院2.5次、住院时长7.6天。
  • 52%患者需输血,平均输血4.3单位;86%接受膀胱镜电灼/血块清除术。

核心结论

  • 文献中前列腺癌放疗后出血性膀胱炎的发病率被低估。
  • 出血性膀胱炎与高疾病负担和并发症相关,需要多次住院、输血和手术操作。
  • 放疗技术的进步并未显著降低出血性膀胱炎的发生风险。

研究设计与样本

  • 回顾性病历回顾研究,纳入2000年1月至2015年9月在两家底特律医学中心接受前列腺癌放疗的709例患者。
  • 对发生出血性膀胱炎的患者分析发病率、放疗方式、疾病负担、治疗和并发症。

主要发现

  • 前列腺癌放疗后出血性膀胱炎发病率为11.1%。
  • 外照射与调强放疗在出血性膀胱炎发生上无显著差异(P=0.18)。
  • 出血性膀胱炎平均于放疗后79.1个月(范围4-230个月)发生。
  • 平均住院次数2.5次(范围1-9次),平均住院时长7.6天(范围1-42天)。
  • 52%患者需要输血,平均每例输血4.3单位(范围1-33单位);最常见治疗为膀胱镜电灼/血块清除术,占86%。

关键数值与推荐

  • 并发症包括尿路感染、急性肾损伤、尿脓毒症甚至死亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if reported incidence rates of hemorrhagic cystitis after radiation therapy for prostate cancer are accurate, to investigate the effect of different radiation modalities on the development of hemorrhagic cystitis and to assess its morbidity and treatment. MATERIALS AND METHODS: A retrospective chart review was completed of 709 patients at 2 Detroit Medical Center hospitals who underwent radiation therapy for prostate cancer between January 2000 and September 2015. In patients who developed hemorrhagic cystitis, we analyzed the incidence, radiation modality, morbidity, treatment, and complications. RESULTS: The incidence rate of hemorrhagic cystitis after radiation for prostate cancer was 11.1%. There was no significant difference between external beam and intensity-modulated radiation therapy and the development of hemorrhagic cystitis (P = .18). Patients developed hemorrhagic cystitis an average of 79.1 months (4-230 months) after radiation. The average number of admissions was 2.5 (1-9) with an average length of stay of 7.6 days (1-42 days). Fifty-two percent of patients required blood transfusion with an average of 4.3 units transfused per patient (1-33U). The most common treatment was cystoscopy with fulguration/clot evacuation in 86% of patients. Complications included urinary tract infection, acute kidney injury, urosepsis, and even death. CONCLUSION: The incidence of hemorrhagic cystitis following radiation therapy for prostate cancer is under-reported in the literature. Hemorrhagic cystitis is associated with high morbidity and complications for patients, requiring multiple hospitalizations, blood transfusions, and procedures. Advances in radiation have not significantly reduced the risk of developing hemorrhagic cystitis.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Martin SE, Begun EM, Samir E, et al. Incidence and Morbidity of Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer. Urology. 2019. PMID: 31201826. doi:10.1016/j.urology.2019.05.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。